Pediatric ID News

I became hooked on ID for the classic reasons — formative experiences in medical school and residency, a deep connection and kinship with supervising ID physicians during fellowship, immense learning opportunities, unforgettable mentor experiences, and tremendous personal and professional growth prospects.

Last year, U.S. Surgeon General Vivek Murthy, MD, issued an advisory on health worker burnout and well-being, declaring the situation a “crisis” and naming it a “top national priority.”

There has been an alarming increase in extensively drug-resistant Shigella infections reported through national surveillance systems.

The FDA on Monday approved a monoclonal antibody for the prevention of respiratory syncytial virus lower respiratory tract disease in newborn and infants.

Last month, Pfizer announced that it was facing a “limited supply and impending stock out” for two of its injectable penicillin products, in part because of a surge in syphilis infections.

American Indian and Alaska Native children endure high rates of respiratory syncytial virus infection, a study published in Pediatrics found.

Takeda’s dengue vaccine candidate is no longer under review for approval in the United States.

Children with mitochondrial disorders have altered B cell function, which weakens their immune response to viral infections, according to study results published in Frontiers in Immunology.

The introduction of eight WHO-recommended vaccines into national immunization schedules slowed during the COVID-19 pandemic, researchers reported in MMWR.

A total of 18 million doses of the world’s first malaria vaccine will be allocated to 12 countries in Africa, WHO announced Wednesday.